Wikidata

(Q61935980)

English

Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting.

clinical trial

In more languages

Statements

short name
ReNew (English)
0 references
title
Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Australia
0 references
start time
January 2010
0 references
end time
April 2013
0 references
number of participants
49
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61935980&oldid=2108109219"